Cargando…

Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy

Detalles Bibliográficos
Autores principales:	dos Santos, Rafael G., Bouso, José C., Hallak, Jaime E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023165/ https://www.ncbi.nlm.nih.gov/pubmed/32491039 http://dx.doi.org/10.1590/1516-4446-2020-1035

Ejemplares similares

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2019)

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2021)

Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023)

Psychedelic medicine and the clinical application of hallucinogens
por: eClinicalMedicine
Publicado: (2023)

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature
por: Rocha, Juliana M., et al.
Publicado: (2019)

Psychedelic drugs as new tools in psychiatric therapeutics
por: Schenberg, Eduardo E.
Publicado: (2020)

Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
por: Bouso, José Carlos, et al.
Publicado: (2023)

Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach
por: dos Santos, Rafael G., et al.
Publicado: (2023)

A Non-Hallucinogenic Psychedelic Analog with Therapeutic Potential
por: Cameron, Lindsay P., et al.
Publicado: (2020)

Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
por: Rossi, Giordano Novak, et al.
Publicado: (2022)

Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens
por: Dupuis, David
Publicado: (2021)

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study
por: Révész, Dóra, et al.
Publicado: (2021)

Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions
por: Girala, N.
Publicado: (2022)

PROPOSAL FOR SYMPOSIUM –ANCIPS, 2022 The New Era Of Psychedelic (Hallucinogen) Associated Treatments In Psychiatry-Will It Be A Game Changer?
por: Jabbar, Jassar Abdul, et al.
Publicado: (2022)

Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
por: Durante, ĺcaro, et al.
Publicado: (2020)

Psychedelics and psychiatric disorders: A emerging role
por: Peixoto, C., et al.
Publicado: (2021)

Translational evidence for ayahuasca as an antidepressant: what’s next?
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2019)

RESURRECTION OF THE CASE REPORT!
por: Shyam, Ashok, et al.
Publicado: (2011)

Is Shame Hallucinogenic?
por: McCarthy-Jones, Simon
Publicado: (2017)

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
por: Jones, Grant, et al.
Publicado: (2023)

Current status of psychedelic therapy in Australia and New Zealand: Are we falling behind?
por: Inserra, Antonio
Publicado: (2019)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Psychedelics and neural plasticity
por: Sumner, Rachael, et al.
Publicado: (2023)

Poisonous & hallucinogenic mushrooms
por: Haard, Richard
Publicado: (1980)

The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
por: Palhano-Fontes, Fernanda, et al.
Publicado: (2015)

Adjuvant interferon in melanoma – a resurrection?
por: Middleton, M R, et al.
Publicado: (2001)

Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020)
por: dos Santos, Rafael G., et al.
Publicado: (2020)

The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences
por: Frymann, Tomas, et al.
Publicado: (2022)

Resurrection of Endovascular Thrombectomy for Posterior Circulation Stroke
por: Kim, Jong S.
Publicado: (2022)

Brain mechanisms of hallucinogens and entactogens
por: Vollenweider, Franz X.
Publicado: (2001)

Psychedelic science in post-COVID-19 psychiatry
por: Kelly, J. R., et al.
Publicado: (2020)

Chronic psychosis associated with new hallucinogenic drug 25I-NBOMe
por: Martin-Santiago, O., et al.
Publicado: (2023)

Hallucinogenic and poisonous mushroom field guide /
por: Menser, Gary P.
Publicado: (1977)

Resurrection
por: Tolstoi, León, 1828-1910
Publicado: (1961)

Resurrections
por: Bernini, Lorenzo
Publicado: (2016)

Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination
por: Jiménez-Garrido, Daniel F., et al.
Publicado: (2020)

Resurrection of Hereditas, a journal with almost 100 years of tradition
por: Baumgartner, Stefan
Publicado: (2015)

Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?
por: Müller, Felix, et al.
Publicado: (2020)

Modulation of Social Cognition via Hallucinogens and “Entactogens”
por: Preller, Katrin H., et al.
Publicado: (2019)

The Potential Role of Serotonergic Hallucinogens in Depression Treatment
por: Psiuk, Dominika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_scmlkieu1k1k64h0klgk8e6rhi